852532-64-0 Usage
Uses
Used in Pharmaceutical Research and Development:
Thieno[2,3-c]pyridine-7-carboxylic acid (9CI) is utilized as a building block in the synthesis of various pharmaceutical drugs. Its unique structure and biological activities make it a valuable component in the creation of new therapeutic agents.
Used in Organic Synthesis:
As a heterocyclic compound, Thieno[2,3-c]pyridine-7-carboxylic acid (9CI) is employed as an intermediate in organic synthesis, contributing to the development of complex organic molecules with potential applications in various industries.
Used in Anti-inflammatory Applications:
Thieno[2,3-c]pyridine-7-carboxylic acid (9CI) is studied for its potential anti-inflammatory properties, making it a candidate for the development of treatments targeting inflammation-related conditions.
Used in Anticancer Applications:
Thieno[2,3-c]pyridine-7-carboxylic acid (9CI) has been investigated for its anti-cancer properties, indicating its potential use in the development of cancer therapeutics. It may contribute to the inhibition of tumor growth and the modulation of cancer-related signaling pathways.
Used in Detection of Metal Ions:
Thieno[2,3-c]pyridine-7-carboxylic acid (9CI) has shown potential as a fluorescent probe for detecting metal ions. This application makes it valuable in research and industrial settings where the detection and analysis of metal ions are required.
Check Digit Verification of cas no
The CAS Registry Mumber 852532-64-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,2,5,3 and 2 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 852532-64:
(8*8)+(7*5)+(6*2)+(5*5)+(4*3)+(3*2)+(2*6)+(1*4)=170
170 % 10 = 0
So 852532-64-0 is a valid CAS Registry Number.
852532-64-0Relevant academic research and scientific papers
Structure-guided design of substituted aza-benzimidazoles as potent hypoxia inducible factor-1α prolyl hydroxylase-2 inhibitors
Frohn, Mike,Viswanadhan, Vellarkad,Pickrell, Alexander J.,Golden, Jennifer E.,Muller, Kristine M.,Buerli, Roland W.,Biddlecome, Gloria,Yoder, Sean C.,Rogers, Norma,Dao, Jennifer H.,Hungate, Randall,Allen, Jennifer R.
scheme or table, p. 5023 - 5026 (2009/05/26)
We report the structure-based design and synthesis of a novel series of aza-benzimidazoles as PHD2 inhibitors. These efforts resulted in compound 22, which displayed highly potent inhibition of PHD2 function in vitro.
